首页> 外文期刊>Journal of hematotherapy and stem cell research >Osteoprotegerin inhibits proliferation of myeloid progenitor cells.
【24h】

Osteoprotegerin inhibits proliferation of myeloid progenitor cells.

机译:骨保护素抑制骨髓祖细胞的增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

Osteoprotegerin (OPG) and decoy receptor 3 (DcR) are soluble members of the tumor necrosis factor receptor (TNFR) superfamily. Because the proteins are found in the circulation, their effect on hematopoietic progenitor cells was examined. OPG suppressed colony formation by all myeloid progenitor cells stimulated with one or more growth factors. OPG suppressed colony formation by granulocyte, granulocyte-macrophage, erythroid, and multipotential progenitors. Suppression was 64.2-35.0% of control. Although OPG and DcR3 contain approximately 43% identity and approximately 62% similar amino acids in their TNFR-motif-containing regions, DcR3 did not show any effects on hematopoietic progenitor cell proliferation. The data indicate that OPG has a broader spectrum of activity than previously defined and that myelosuppression may need to be monitored for when OPG is used clinically.
机译:骨保护素(OPG)和诱饵受体3(DcR)是肿瘤坏死因子受体(TNFR)超家族的可溶性成员。因为在循环中发现了蛋白质,所以检查了它们对造血祖细胞的作用。 OPG抑制了受一种或多种生长因子刺激的所有骨髓祖细胞的集落形成。 OPG可抑制粒细胞,粒细胞巨噬细胞,红系和多能祖细胞形成的菌落。抑制率为对照的64.2-35.0%。尽管OPG和DcR3在其包含TNFR-基序的区域中包含约43%的同一性和约62%的相似氨基酸,但DcR3对造血祖细胞的增殖没有任何影响。数据表明OPG具有比以前定义的更广泛的活性谱,并且可能需要监测临床上使用OPG时的骨髓抑制情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号